𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prophylaxis of central nervous system leukemia: a case of chronic myeloid leukemia with lymphoid blast crisis treated with imatinib mesylate

✍ Scribed by Vasantha Thavaraj; Rachna Seth


Publisher
SP Children’s Hospital, Zhejiang University School of Medicine
Year
2008
Tongue
English
Weight
86 KB
Volume
4
Category
Article
ISSN
1708-8569

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Is it possible to discontinue imatinib m
✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o